Patents by Inventor Andreas Menrad

Andreas Menrad has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anthranyl amides and their use as medicaments
    Publication number: 20040029880
    Abstract: Substituted anthranilamides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis as well as their intermediate products for the production of anthranilamides are described.
    Type: Application
    Filed: June 23, 2003
    Publication date: February 12, 2004
    Inventors: Martin Krueger, Andreas Huth, Orlin Petrov, Dieter Seidelmann, Karl-Heinz Thierauch, Martin Haberey, Andreas Menrad, Alexander Ernst
  • Anthranylalkyl and cycloalkyl amides and use thereof as vegf receptor inhibitors
    Publication number: 20030176469
    Abstract: The invention relates to substituted anthranylalkyl and cycloalkyl amides of general formula (I) and to their use as medicaments for treating diseases caused by persistent angiogenesis.
    Type: Application
    Filed: May 9, 2003
    Publication date: September 18, 2003
    Inventors: Dieter Seidelmann, Martin Kruger, Eckhard Ottow, Andreas Huth, Karl-heinz Thierauch, Andreas Menrad, Martin Haberey
  • N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors
    Publication number: 20030064992
    Abstract: 1
    Type: Application
    Filed: June 26, 2002
    Publication date: April 3, 2003
    Inventors: Karl-Heinz Altmann, Guido Bold, Pascal Furet, Paul William Manley, Jeanette Marjorie Wood, Stefano Ferrari, Francesco Hofmann, Jurgen Mestan, Andreas Huth, Martin Kruger, Dieter Seidelmann, Andreas Menrad, Martin Haberey, Karl-Heinz Thierauch
  • Receptor of the EDb-fibronectin domains
    Publication number: 20020197700
    Abstract: The invention relates to a protein that binds specifically to the EDb-fibronectin domains, process for screening compounds that bind to a receptor of the EDb-fibronectin domains or to EDb-fibronectin domains themselves, as well as the uses of protein.
    Type: Application
    Filed: August 30, 2001
    Publication date: December 26, 2002
    Applicant: Schering AG
    Inventors: Andreas Menrad, Alexander Redlitz, Marcus Kopplitz, Ursula Egner, Inke Bahr
  • VEGF receptor tyrosine kinase inhibitors
    Patent number: 6448277
    Abstract: Described are compounds of formula (I), wherein W is O or S; X is NR8; Y is CR9R10—(CH2)n wherein R9 and R10 are independently of each other hydrogen or lower alkyl, and n is an integer of from and including 0 to and including 3; or Y is S02; R1 is aryl; R2 is a mono- or bicyclic heteroaryl group comprising one or more ring nitrogen atoms with the exception that R2 cannot represent 2-phthalimidyl, and in case of Y=SO2 cannot represent 2,1,3-benzothiadiazol-4-yl; any of R3, R4, R5 and R6, independently of the other, is H or a substituent other than hydrogen; and R7 and R8, independently of each other, are H or lower alkyl; or a N-oxide or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical product for the treatment of a neoplastic disease which responds to an inhibition of the VEGF receptor tyrosine kinase activity. The compounds of formula (I) can be used for the treatment e.g.
    Type: Grant
    Filed: May 7, 2001
    Date of Patent: September 10, 2002
    Assignees: Novartis AG, Schering Aktiengesellschaft
    Inventors: Karl-Heinz Altmann, Guido Bold, Pascal Furet, Paul William Manley, Jeanette Marjorie Wood, Stefano Ferrari, Francesco Hofmann, Jürgen Mestan, Andreas Huth, Martin Krüger, Dieter Seidelmann, Andreas Menrad, Martin Haberey, Karl-Heinz Thierauch
  • Vitamin D derivatives with substituents at C-25, process for their production, intermediate products and use for the production of pharmaceutical agents
    Patent number: 6376480
    Abstract: A method of preparing a pharmaceutical composition, comprising combining a pharmaceutically compatible vehicle with a compound according to formula (I)
    Type: Grant
    Filed: December 18, 2000
    Date of Patent: April 23, 2002
    Assignee: Schering Aktiengesellschaft
    Inventors: Gerald Kirsch, Andreas Steinmeyer, Günter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Andreas Menrad, Martin Haberey
  • Vitamin D derivatives with C-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments
    Patent number: 6372731
    Abstract: A vitamin D derivative and its uses with substituents at C-25 of general formula I
    Type: Grant
    Filed: March 31, 1998
    Date of Patent: April 16, 2002
    Assignee: Schering Aktiengesellschaft
    Inventors: Gerald Kirsch, Andreas Steinmeyer, Günter Neef, Katica Schwarz, Ruth Thieroff-Ekerdt, Herbert Wiesinger, Andreas Menrad, Martin Haberey
  • N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors
    Publication number: 20020019414
    Abstract: 1
    Type: Application
    Filed: May 7, 2001
    Publication date: February 14, 2002
    Inventors: Karl-Heinz Altmann, Guido Bold, Pascal Furet, Paul William Manley, Jeanette Marjorie Wood, Stefano Ferrari, Francesco Hofmann, Jurgen Mestan, Andreas Huth, Martin Kruger, Dieter Seidelmann, Andreas Menrad, Martin Haberey, Karl-Heinz Thierauch
  • Monoclonal antibodies against the extracellular domain of human VEGF-receptor protein (KDR)
    Patent number: 6344339
    Abstract: Monoclonal antibodies, secreted by hybridoma cell lines, that are directed against an epitope of the extracellular domain of human VEGF-receptor KDR, methods of determining human VEGF-receptor KDR in cell lysates or tissue analysates and the use of the antibodies in analytical assays, in diagnostics and as carrier molecules for therapeutic substances, are described.
    Type: Grant
    Filed: May 19, 1999
    Date of Patent: February 5, 2002
    Assignee: Schering Aktiengesellschaft
    Inventors: Andreas Menrad, Karl-Heinz Thierauch, Georg Martiny-Baron, Frank Totzke